Prospective Granting of a Co-Exclusive License, 57630 [E8-23398]
Download as PDF
<![CDATA[
57630
Federal Register / Vol. 73, No. 193 / Friday, October 3, 2008 / Notices
management activities for both CDC and
the Agency for Toxic Substances and
Disease Registry.
Dated: September 25, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–23397 Filed 10–2–08; 8:45 am]
BILLING CODE 4160–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
treated as objections to the grant of the
contemplated co-exclusive license. Only
written comments and/or applications
for a license which are received by CDC
within thirty days of this notice will be
considered. Comments and objections
submitted in response to this notice will
not be made available for public
inspection, and, to the extent permitted
by law, will not be released under the
Freedom of Information Act, 5 U.S.C.
552. A signed Confidential Disclosure
Agreement will be required to receive a
copy of any pending patent application.
Dated: September 26, 2008.
James D. Seligman,
Chief Information Officer, Centers for Disease
Control and Prevention.
[FR Doc. E8–23398 Filed 10–2–08; 8:45 am]
Centers for Disease Control and
Prevention
Prospective Granting of a CoExclusive License
BILLING CODE 4163–18–P
Technology Transfer Office,
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
This is a notice in accordance
with 35 U.S.C. 209(e) and 37 CFR
404.7(a)(1)(i) that the Technology
Transfer Office, Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (DHHS), is contemplating the
granting of a co-exclusive worldwide
license to practice the invention
embodied in the patent application
referred below to Mk-IX Technologies,
having a place of business in Huntsville,
Alabama. CDC intends to grant rights to
practice this invention to no more than
one other co-licensee. The patent rights
in these inventions have been assigned
to the government of the United States
of America. The patent application to be
licensed is:
SUMMARY:
mstockstill on PROD1PC66 with NOTICES
Non-Provisional Patent Application
Title: Wipes and Methods for Removal
of Metal Contamination from Surfaces.
Serial No. 11/039,178.
Filing date: 01/18/2005.
Issue Date: Patent pending.
The prospective exclusive license will
be royalty-bearing and will comply with
the terms and conditions of 35 U.S.C.
209 and 37 CFR 404.7.
ADDRESSES: Requests for a copy of these
patent applications, inquiries,
comments, and other materials relating
to the contemplated license should be
directed to Andrew Watkins, Director,
Technology Transfer Office, Centers for
Disease Control and Prevention (CDC),
4770 Buford Highway, Mailstop K–79,
Atlanta, GA 30341, telephone: (770)
488–8610; facsimile: (770) 488–8615.
Applications for an exclusive license
filed in response to this notice will be
VerDate Aug<31>2005
23:33 Oct 02, 2008
Jkt 217001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10001, CMS–
10009, CMS–10272 and CMS–10242]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, HHS.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS) is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Health
Insurance Portability and
Accountability Act (HIPAA)
Nondiscrimination Provisions and
Supporting Regulations in 45 CFR
146.121(h) and 121(i)(2)(i); Use: If
AGENCY:
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
coverage has been denied to any
individual because the sponsor of a selffunded non-Federal governmental plan
had exempt the plan from the
nondiscrimination requirements under
45 CFR 146.180 ‘‘Treatment of NonFederal Governmental Plans’’, and the
plan sponsor subsequently chooses to
bring the plan into compliance, the plan
sponsor must comply with the
requirements under 45 CFR
146.121(i)(2)(i) ‘‘Special Transitional
Rule for Self-Funded Non-Federal
Governmental Plans Exempted under 45
CFR 146.180’’. To bring the plan into
compliance with the requirements, the
plan must notify the individual that the
plan will be coming into compliance,
afford the individual an opportunity to
enroll, specify the effective date of
compliance, and inform the individual
regarding any enrollment restrictions
that may apply under the terms of the
plan once the plan is in compliance.
Form Number: CMS–10001 (OMB#
0938–0827); Frequency: Yearly; Affected
Public: State, Local, or Tribal
Governments; Number of Respondents:
18; Total Annual Responses: 18; Total
Annual Hours: 194.
2. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Health
Insurance Portability and
Accountability Act (HIPAA)
Nondiscrimination Provisions and
Supporting Regulations in 45 CFR
146.121(f)(2)(v)(A); Use: Section 146.121
of the regulations requires Health plans
or issuers to disclose in all plan
materials the terms of certain wellness
programs including the availability of a
reasonable alternative standard. Plan
participants and their dependents need
this information to understand the
rights they have under HIPAA. States
and the Federal government may need
the information supplied by issuers to
properly perform their regulatory
functions. Form Number: CMS–10009
(OMB# 0938–0819); Frequency: Yearly;
Affected Public: State, Local, or Tribal
Governments; Number of Respondents:
2,600; Total Annual Responses: 2,600;
Total Annual Hours: 1,300.
3. Type of Information Collection
Request: New collection; Title of
Information Collection: Hospital
Leadership Quality Assessment Tool
(HLQAT); Use: In 2006, the Hospital
Leadership Collaborative (HLC)
launched a public-private partnership to
develop a CMS-endorsed selfassessment tool, ‘‘The Hospital
Leadership and Quality Assessment
Tool’’ (HLQAT) to assist hospitals in the
improvement of quality through
enhanced hospital governance,
E:\FR\FM\03OCN1.SGM
03OCN1
]]>Agencies
[Federal Register Volume 73, Number 193 (Friday, October 3, 2008)]
[Notices]
[Page 57630]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-23398]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Prospective Granting of a Co-Exclusive License
AGENCY: Technology Transfer Office, Centers for Disease Control and
Prevention (CDC), Department of Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This is a notice in accordance with 35 U.S.C. 209(e) and 37
CFR 404.7(a)(1)(i) that the Technology Transfer Office, Centers for
Disease Control and Prevention (CDC), Department of Health and Human
Services (DHHS), is contemplating the granting of a co-exclusive
worldwide license to practice the invention embodied in the patent
application referred below to Mk-IX Technologies, having a place of
business in Huntsville, Alabama. CDC intends to grant rights to
practice this invention to no more than one other co-licensee. The
patent rights in these inventions have been assigned to the government
of the United States of America. The patent application to be licensed
is:
Non-Provisional Patent Application
Title: Wipes and Methods for Removal of Metal Contamination from
Surfaces.
Serial No. 11/039,178.
Filing date: 01/18/2005.
Issue Date: Patent pending.
The prospective exclusive license will be royalty-bearing and will
comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7.
ADDRESSES: Requests for a copy of these patent applications, inquiries,
comments, and other materials relating to the contemplated license
should be directed to Andrew Watkins, Director, Technology Transfer
Office, Centers for Disease Control and Prevention (CDC), 4770 Buford
Highway, Mailstop K-79, Atlanta, GA 30341, telephone: (770) 488-8610;
facsimile: (770) 488-8615. Applications for an exclusive license filed
in response to this notice will be treated as objections to the grant
of the contemplated co-exclusive license. Only written comments and/or
applications for a license which are received by CDC within thirty days
of this notice will be considered. Comments and objections submitted in
response to this notice will not be made available for public
inspection, and, to the extent permitted by law, will not be released
under the Freedom of Information Act, 5 U.S.C. 552. A signed
Confidential Disclosure Agreement will be required to receive a copy of
any pending patent application.
Dated: September 26, 2008.
James D. Seligman,
Chief Information Officer, Centers for Disease Control and Prevention.
[FR Doc. E8-23398 Filed 10-2-08; 8:45 am]
BILLING CODE 4163-18-P
